(1 - 11 von 13
)
BRIEF-Blueprint Medicines appoints Marion Dorsch chief scientific...
www.reuters.com
* Blueprint Medicines announces appointment of Marion Dorsch, PH.D. as chief scientific officer and the transition of Christoph Lengauer, PH.D., MBA, to a...
Blueprint Medicines Appoints Oncology Drug Development Leader...
www.finanznachrichten.de
Blueprint Medicines, a company harnessing the understanding of the molecular blueprint of cancer to develop personalized, highly-selective cancer therapies,...
Blueprint Medicines to Present on the First Isoform
www.globenewswire.com
The presentation by Blueprint's Chief Scientific Officer Christoph Lengauer, Ph.D., will include preclinical data examining the impact of isoform ...
Horizon Discovery and Blueprint Medicines Enter Oncology ...www.technologynetworks.com › ... › News
www.technologynetworks.com
· Dr. Christoph Lengauer, Chief Scientific Officer at Blueprint Medicines, commented: “Horizon's track record in precise genome engineering of ...
sortiert nach Relevanz / Datum